Oxalate nephropathy complicating Roux-en-Y Gastric bypass

An underrecognized cause of irreversible renal failure

Samih H. Nasr, Vivette D. D'Agati, Samar M. Said, Michael B. Stokes, Maria V. Largoza, Jai Radhakrishnan, Glen S. Markowitz

Research output: Contribution to journalArticle

111 Citations (Scopus)

Abstract

Background and objectives: The most common bariatric surgery is Roux-en-Y gastric bypass (RYGB), which has been associated with hyperoxaluria and nephrolithiasis. We report a novel association of RYGB with renal insufficiency as a result of oxalate nephropathy. Design, setting, participants, & measurements: Eleven cases of oxalate nephropathy after RYGB were identified from the Renal Pathology Laboratory of Columbia University. The clinical features, pathologic findings, and outcomes are described. Results: Patients were predominantly white (72.7%) with a mean age of 61.3 yr. Indications for RYGB included morbid obesity (eight patients) and reconstruction after total gastrectomy for gastric cancer (three patients). All 11 patients had a history of hypertension, and 9 were diabetic. Patients presented with acute renal failure, often superimposed on mild chronic renal insufficiency (n = 7), at a median of 12 mo after RYGB. The mean creatinine at baseline, at discovery of acute renal failure, and at biopsy was 1.5, 5.0, and 6.5 mg/dl, respectively. Renal biopsies revealed diffuse tubular degenerative changes, abundant tubular calcium oxalate deposits, and varying degrees of tubulointerstitial scarring. In addition, seven biopsies had underlying diabetic glomerulosclerosis and two had glomerulosclerosis attributable to obesity and hypertension. Eight of 11 patients rapidly progressed to ESRD and required hemodialysis at a mean of 3.2 wk after renal biopsy. The remaining three patients were left with significant chronic kidney disease. Conclusions: Oxalate nephropathy is an underrecognized complication of RYGB and typically results in rapid progression to ESRD. Patients with pre-existing renal disease may be at higher risk for this complication.

Original languageEnglish (US)
Pages (from-to)1676-1683
Number of pages8
JournalClinical Journal of the American Society of Nephrology
Volume3
Issue number6
DOIs
StatePublished - Nov 1 2008
Externally publishedYes

Fingerprint

Gastric Bypass
Oxalates
Renal Insufficiency
Kidney
Biopsy
Chronic Renal Insufficiency
Acute Kidney Injury
Chronic Kidney Failure
Hyperoxaluria
Hypertension
Nephrolithiasis
Calcium Oxalate
Preexisting Condition Coverage
Bariatric Surgery
Morbid Obesity
Diabetic Nephropathies
Gastrectomy
Stomach Neoplasms
Cicatrix
Renal Dialysis

ASJC Scopus subject areas

  • Medicine(all)
  • Critical Care and Intensive Care Medicine
  • Epidemiology
  • Nephrology
  • Transplantation

Cite this

Nasr, S. H., D'Agati, V. D., Said, S. M., Stokes, M. B., Largoza, M. V., Radhakrishnan, J., & Markowitz, G. S. (2008). Oxalate nephropathy complicating Roux-en-Y Gastric bypass: An underrecognized cause of irreversible renal failure. Clinical Journal of the American Society of Nephrology, 3(6), 1676-1683. https://doi.org/10.2215/CJN.02940608

Oxalate nephropathy complicating Roux-en-Y Gastric bypass : An underrecognized cause of irreversible renal failure. / Nasr, Samih H.; D'Agati, Vivette D.; Said, Samar M.; Stokes, Michael B.; Largoza, Maria V.; Radhakrishnan, Jai; Markowitz, Glen S.

In: Clinical Journal of the American Society of Nephrology, Vol. 3, No. 6, 01.11.2008, p. 1676-1683.

Research output: Contribution to journalArticle

Nasr, Samih H. ; D'Agati, Vivette D. ; Said, Samar M. ; Stokes, Michael B. ; Largoza, Maria V. ; Radhakrishnan, Jai ; Markowitz, Glen S. / Oxalate nephropathy complicating Roux-en-Y Gastric bypass : An underrecognized cause of irreversible renal failure. In: Clinical Journal of the American Society of Nephrology. 2008 ; Vol. 3, No. 6. pp. 1676-1683.
@article{85f66c9672414c5c9c847613f3956a10,
title = "Oxalate nephropathy complicating Roux-en-Y Gastric bypass: An underrecognized cause of irreversible renal failure",
abstract = "Background and objectives: The most common bariatric surgery is Roux-en-Y gastric bypass (RYGB), which has been associated with hyperoxaluria and nephrolithiasis. We report a novel association of RYGB with renal insufficiency as a result of oxalate nephropathy. Design, setting, participants, & measurements: Eleven cases of oxalate nephropathy after RYGB were identified from the Renal Pathology Laboratory of Columbia University. The clinical features, pathologic findings, and outcomes are described. Results: Patients were predominantly white (72.7{\%}) with a mean age of 61.3 yr. Indications for RYGB included morbid obesity (eight patients) and reconstruction after total gastrectomy for gastric cancer (three patients). All 11 patients had a history of hypertension, and 9 were diabetic. Patients presented with acute renal failure, often superimposed on mild chronic renal insufficiency (n = 7), at a median of 12 mo after RYGB. The mean creatinine at baseline, at discovery of acute renal failure, and at biopsy was 1.5, 5.0, and 6.5 mg/dl, respectively. Renal biopsies revealed diffuse tubular degenerative changes, abundant tubular calcium oxalate deposits, and varying degrees of tubulointerstitial scarring. In addition, seven biopsies had underlying diabetic glomerulosclerosis and two had glomerulosclerosis attributable to obesity and hypertension. Eight of 11 patients rapidly progressed to ESRD and required hemodialysis at a mean of 3.2 wk after renal biopsy. The remaining three patients were left with significant chronic kidney disease. Conclusions: Oxalate nephropathy is an underrecognized complication of RYGB and typically results in rapid progression to ESRD. Patients with pre-existing renal disease may be at higher risk for this complication.",
author = "Nasr, {Samih H.} and D'Agati, {Vivette D.} and Said, {Samar M.} and Stokes, {Michael B.} and Largoza, {Maria V.} and Jai Radhakrishnan and Markowitz, {Glen S.}",
year = "2008",
month = "11",
day = "1",
doi = "10.2215/CJN.02940608",
language = "English (US)",
volume = "3",
pages = "1676--1683",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "6",

}

TY - JOUR

T1 - Oxalate nephropathy complicating Roux-en-Y Gastric bypass

T2 - An underrecognized cause of irreversible renal failure

AU - Nasr, Samih H.

AU - D'Agati, Vivette D.

AU - Said, Samar M.

AU - Stokes, Michael B.

AU - Largoza, Maria V.

AU - Radhakrishnan, Jai

AU - Markowitz, Glen S.

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Background and objectives: The most common bariatric surgery is Roux-en-Y gastric bypass (RYGB), which has been associated with hyperoxaluria and nephrolithiasis. We report a novel association of RYGB with renal insufficiency as a result of oxalate nephropathy. Design, setting, participants, & measurements: Eleven cases of oxalate nephropathy after RYGB were identified from the Renal Pathology Laboratory of Columbia University. The clinical features, pathologic findings, and outcomes are described. Results: Patients were predominantly white (72.7%) with a mean age of 61.3 yr. Indications for RYGB included morbid obesity (eight patients) and reconstruction after total gastrectomy for gastric cancer (three patients). All 11 patients had a history of hypertension, and 9 were diabetic. Patients presented with acute renal failure, often superimposed on mild chronic renal insufficiency (n = 7), at a median of 12 mo after RYGB. The mean creatinine at baseline, at discovery of acute renal failure, and at biopsy was 1.5, 5.0, and 6.5 mg/dl, respectively. Renal biopsies revealed diffuse tubular degenerative changes, abundant tubular calcium oxalate deposits, and varying degrees of tubulointerstitial scarring. In addition, seven biopsies had underlying diabetic glomerulosclerosis and two had glomerulosclerosis attributable to obesity and hypertension. Eight of 11 patients rapidly progressed to ESRD and required hemodialysis at a mean of 3.2 wk after renal biopsy. The remaining three patients were left with significant chronic kidney disease. Conclusions: Oxalate nephropathy is an underrecognized complication of RYGB and typically results in rapid progression to ESRD. Patients with pre-existing renal disease may be at higher risk for this complication.

AB - Background and objectives: The most common bariatric surgery is Roux-en-Y gastric bypass (RYGB), which has been associated with hyperoxaluria and nephrolithiasis. We report a novel association of RYGB with renal insufficiency as a result of oxalate nephropathy. Design, setting, participants, & measurements: Eleven cases of oxalate nephropathy after RYGB were identified from the Renal Pathology Laboratory of Columbia University. The clinical features, pathologic findings, and outcomes are described. Results: Patients were predominantly white (72.7%) with a mean age of 61.3 yr. Indications for RYGB included morbid obesity (eight patients) and reconstruction after total gastrectomy for gastric cancer (three patients). All 11 patients had a history of hypertension, and 9 were diabetic. Patients presented with acute renal failure, often superimposed on mild chronic renal insufficiency (n = 7), at a median of 12 mo after RYGB. The mean creatinine at baseline, at discovery of acute renal failure, and at biopsy was 1.5, 5.0, and 6.5 mg/dl, respectively. Renal biopsies revealed diffuse tubular degenerative changes, abundant tubular calcium oxalate deposits, and varying degrees of tubulointerstitial scarring. In addition, seven biopsies had underlying diabetic glomerulosclerosis and two had glomerulosclerosis attributable to obesity and hypertension. Eight of 11 patients rapidly progressed to ESRD and required hemodialysis at a mean of 3.2 wk after renal biopsy. The remaining three patients were left with significant chronic kidney disease. Conclusions: Oxalate nephropathy is an underrecognized complication of RYGB and typically results in rapid progression to ESRD. Patients with pre-existing renal disease may be at higher risk for this complication.

UR - http://www.scopus.com/inward/record.url?scp=58149354522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149354522&partnerID=8YFLogxK

U2 - 10.2215/CJN.02940608

DO - 10.2215/CJN.02940608

M3 - Article

VL - 3

SP - 1676

EP - 1683

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

SN - 1555-9041

IS - 6

ER -